Dr. Ouellette’s passion is enabling clients to clarify strategy, de-risk development, and position assets for partnership, investment, and long-term value creation. He brings a combination of scientific depth, intellectual property expertise, and frontline business development experience with previous roles in biotech startups, law firms, and growth-stage companies. He has worked directly with biopharma clients to design data-driven strategies for drug development, indication expansion, and biomarker development. Earlier in his career at Cooley LLP, he managed global patent portfolios and conducted due diligence for venture financings, IPOs, and M&A transactions. He holds a Ph.D. focused on Cancer Biology and Molecular Pharmacology from Purdue University and is a USPTO-registered Patent Agent.